堂本貴寛

ドウモトタカヒロ | Domoto Takahiro

所属機関・部署：
職名：助教

研究分野 (1件)：腫瘍生物学

研究キーワード (3件)：転移 , 浸潤 , 分子腫瘍学

競争的資金等の研究課題 (6件)：

全件表示

論文 (31件)：

Masahiro Uehara, Takahiro Domoto, Satoshi Takenaka, Osamu Takeuchi, Takeo Shimasaki, Tomoharu Miyashita, Toshinari Minamoto. Glycogen synthase kinase 3β: the nexus of chemoresistance, invasive capacity, and cancer stemness in pancreatic cancer. Cancer Drug Resistance. 2024
Keita Koizumi, Takahiro Domoto, Toshinari Minamoto, Kazuhito Kazuhito, Hideo Nakajima. Deactivation of glycogen synthase kinase-3β by heat shock-inducible tumor small protein attenuates hyperthermia-induced pro-migratory activity in colorectal cancer cells. International Journal of Oncology. 2023. 63. 2
Hiroya Kondo, Kenji Mishiro, Yuki Iwashima, Yujia Qiu, Akiko Kobayashi, Keesiang Lim, Takahiro Domoto, Toshinari Minamoto, Kazuma Ogawa, Munetaka Kunishima, et al. Discovery of a novel aminocyclopropenone compound that Inhibits BRD4-driven nucleoporin NUP210 expression and attenuates colorectal cancer growth. Cells. 2022. 11. 3. 317-317
Kensaku Abe, Shingo Shimozaki, Takahiro Domoto, Norio Yamamoto, Hiroyuki Tsuchiya, Toshinari Minamoto. Glycogen synthase kinase 3β biology in bone and soft tissue sarcomas. Journal of Cancer Metastasis and Treatment. 2020. 2020
Masahiro Uehara, Takahiro Domoto, Satoshi Takenaka, Dilireba Bolidong, Osamu Takeuchi, Tomoharu Miyashita, Toshinari Minamoto. Glycogen synthase kinase-3β participates in acquired resistance to gemcitabine in pancreatic cancer. Cancer Science. 2020. 111. 12. 4405-4416

MISC (16件)：

書籍 (1件)：

講演・口頭発表等 (39件)：

Potential therapeutic effect of preclinical GSK3β inhibitor in pancreatic cancer with resistance to gemcitabine
(第34回日本消化器癌発生学会総会 2023)
A new preclinical GSK3β inhibitor overcomes acquired resistance to gemcitabine in pancreatic cancer
(第82回日本癌学会学術総会 2023)
GSK3β integrates acquired chemoresistance, invasive capacity and tumor stemness in refractory pancreatic cancer
(第33回日本消化器癌発生学会総会 2022)
GSK3β participates in malignant properties of pancreatic cancer acquiring chemoresistance
(第81回日本癌学会学術総会 2022)
GSK3β interconnects tumor invasion and stemness in pancreatic cancer acquiring resistance to gemcitabine
(The 7th JCA-AACR Special Joint Conference The Latest Advances in Pancreatic Research: From Basic Science to Therapeutics 2022)

学位 (1件)：

受賞 (2件)：

所属学会 (3件)：

日本消化器癌発生学会 , 日本癌学会 , 日本がん転移学会

※　J-GLOBALの研究者情報は、researchmapの登録情報に基づき表示しています。登録・更新については、こちらをご覧ください。

堂本 貴寛